Metabolic Syndrome and NASH: Risk for HCC

被引：0
|
作者：
不详
机构：
来源：
DIABETES STOFFWECHSEL UND HERZ | 2022年 / 31卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：190 / 190
页数：1
相关论文
共 50 条
  • [41] Lipogranulomas, neutrophils and the progression of NAFLD to NASH and HCC
    Mauricio, Joao C.
    Mahdi, Ahmed K.
    Lunec, John
    Patman, Gillian
    Whitehead, Anna
    Tiniakos, Dina
    Anstee, Quentin M.
    Oakley, Fiona
    Mann, Derek
    Wilson, Caroline
    Reeves, Helen
    HEPATOLOGY, 2017, 66 : 987A - 988A
  • [42] Microbiota, NASH, HCC and the potential role of probiotics
    Brandi, Giovanni
    De Lorenzo, Stefania
    Candela, Marco
    Pantaleo, Maria Abbondanza
    Bellentani, Stefano
    Tovoli, Francesco
    Saccoccio, Gioconda
    Biasco, Guido
    CARCINOGENESIS, 2017, 38 (03) : 231 - 240
  • [43] HCC and NASH: How strong is the clinical demonstration?
    Rosmorduc, O.
    Fartoux, L.
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2012, 36 (03) : 202 - 208
  • [44] Metabolic syndrome marker profile in patients with hepatocellular carcinoma HCC.
    Guler, Nil
    Scaglione, Steve
    Syed, Daneyal
    Martin, Danyelle
    Hoppensteadt, Debra
    Saluk, Jennifer
    Sandhu, Jasmin
    Palumbo, Rachel
    Layden, Thomas
    Iqbal, Omer M.
    Fareed, Jawed
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [45] THE IMPACT OF METABOLIC SYNDROME (MS) IN THE STAGE AT DIAGNOSIS OF HEPATOCELLULAR CARCINOMA (HCC)
    Tapia-Sosa, Ramiro
    Garcia-juarez, Ignacio
    Kimura-Sandoval, Yumi
    GASTROENTEROLOGY, 2019, 156 (06) : S1182 - S1183
  • [46] Immunotherapy resistance in NASH-HCC is driven by the dysfunctional liver microenvironment of NASH
    Geh, Daniel
    Gil, Erik Ramon
    Laszczewska, Maja
    Collins, Amy
    Luli, Saimir
    Cameron, Rainie
    Oakley, Fiona
    Leslie, Jack
    Reeves, Helen Louise
    Mann, Derek A.
    JOURNAL OF HEPATOLOGY, 2023, 78 : S538 - S539
  • [47] Anti-NASH Effects of Solithromycin in NASH-HCC Mouse Model
    Fernandes, Prabhavathi
    Hashiguchi, Taishi
    Fujii, Masato
    Yoneyama, Hiroyuki
    GASTROENTEROLOGY, 2014, 146 (05) : S145 - S146
  • [48] The Impact of Metabolic Syndrome on the Outcome of NASH: Cirrhosis, Hepatocellular Carcinoma, and Mortality
    Ramy Younes
    Elisabetta Bugianesi
    Current Hepatology Reports, 2018, 17 (4) : 336 - 344
  • [49] ROLE OF DIETARY INTERVENTION IN PATIENTS WITH METABOLIC SYNDROME AND NAFLD-NASH
    Formisano, E.
    Pasta, A.
    Cremonini, A. L.
    Garrubba, C.
    Borro, P.
    Picciotto, A.
    Pisciotta, L.
    ATHEROSCLEROSIS, 2020, 315 : E262 - E262
  • [50] Disordered hepatic cholesterol turnover in mice with metabolic syndrome: relationship to NASH
    Van Rooyen, D. M.
    Larter, C. Z.
    Teoh, N.
    Farrell, G. C.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2009, 24 : A280 - A280
12345